Nautilus to Participate in the Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will participate virtually at the Morgan Stanley Global Healthcare Conference on September 15, 2021, at 1:15 p.m. ET. The event will feature a presentation detailing Nautilus' innovative single-molecule protein analysis platform that quantifies the human proteome. Attendees can access a live and archived webcast through Nautilus' website. The company aims to enhance basic science research and improve therapeutic development through its advanced proteomics technology.

SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference.

Nautilus’ management is scheduled to present on Wednesday, September 15^th at 1:15 p.m. Eastern Time/10:15 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the company’s website at: https://www.nautilus.bio/investors/

About Nautilus Biotechnology, Inc.

Nautilus is a biotechnology company who is developing a proteomics platform that aims to deliver superior sensitivity more quickly, more completely, and less expensively than is currently possible. Nautilus Biotechnology aims to enable a dramatic acceleration of basic science research, significantly improve the success rate of therapeutic development, and enhance opportunities for personalized and predictive medicine.  Nautilus’ corporate headquarters is in Seattle, Washington and scientific research and development is being conducted from its San Carlos, California office and labs. 

Contacts

Investors:
InvestorRelations@nautilus.bio

Media:
Chris Blessington
Vice President, Corporate Marketing and Communications
chrisb@nautilus.bio

FAQ

When is Nautilus Biotechnology presenting at the Morgan Stanley Global Healthcare Conference?

Nautilus Biotechnology will present on September 15, 2021, at 1:15 p.m. Eastern Time.

How can I access the Nautilus Biotechnology conference presentation?

The presentation can be accessed live and on-demand via the Nautilus website.

What is the focus of Nautilus Biotechnology's proteomics platform?

Nautilus' platform focuses on quantifying the human proteome with superior sensitivity and efficiency.

What are the potential benefits of Nautilus Biotechnology's technology?

The technology aims to accelerate basic science research and improve therapeutic development success rates.

Where is Nautilus Biotechnology headquartered?

Nautilus Biotechnology is headquartered in Seattle, Washington.